Literature DB >> 28922083

Strategies in recommending influenza vaccination in Europe and US.

Caterina Rizzo1, Giovanni Rezza1, Walter Ricciardi2,3.   

Abstract

There is potential for influenza vaccine programmes to make a substantial impact on the disease burden. The World Health Organization (WHO) has identified young children, pregnant women, persons with chronic medical conditions, and the elderly as being at risk for severe influenza disease and therefore important groups to be considered for influenza vaccination. Applying the methodology of scoping review of grey and scientific literature we described the European and the US approach to influenza vaccine prevention. Although vaccination remains the most effective means of reducing the incidence and severity of influenza, vaccine uptake in many European countries remains suboptimal (i.e. 45.5% in the elderly, 24% in health care workers, from 49.8% in patients with chronic medical conditions, median 23.6% in pregnant women) and vaccine strategies are not harmonized in particular with regard to vaccinating healthy children. Whereas in the US the vaccine strategies are more standardized across states and vaccine coverage are higher than those reported in EU on average. The integration of different strategies is crucial in order to increase influenza vaccine coverage: public health authorities should encourage healthcare workers to vaccinate themselves, as target category, and to recommend seasonal influenza vaccination to people in the target groups; there should also be structured communication campaigns on influenza and influenza vaccines, directed specifically at these target groups, and an adequate and sustainable funding is also an important factor to achieve higher vaccination coverage rates.

Entities:  

Keywords:  Europe; Influenza vaccine; United States; influenza; vaccination strategies

Mesh:

Substances:

Year:  2018        PMID: 28922083      PMCID: PMC5861797          DOI: 10.1080/21645515.2017.1367463

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  27 in total

1.  ECDC in collaboration with the VAESCO consortium to develop a complementary tool for vaccine safety monitoring in Europe.

Authors: 
Journal:  Euro Surveill       Date:  2009-10-01

2.  Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.

Authors:  Alin Gherasim; Francisco Pozo; Salvador de Mateo; Inma Aspiritxaga Gamarra; Manuel García-Cenoz; Tomas Vega; Eva Martínez; Jaume Giménez; Daniel Castrillejo; Amparo Larrauri
Journal:  Vaccine       Date:  2016-03-25       Impact factor: 3.641

Review 3.  Influenza cost and cost-effectiveness studies globally--a review.

Authors:  Samuel K Peasah; Eduardo Azziz-Baumgartner; Joseph Breese; Martin I Meltzer; Marc-Alain Widdowson
Journal:  Vaccine       Date:  2013-09-19       Impact factor: 3.641

4.  Handwashing and respiratory illness among young adults in military training.

Authors:  M A Ryan; R S Christian; J Wohlrabe
Journal:  Am J Prev Med       Date:  2001-08       Impact factor: 5.043

5.  Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial.

Authors:  Benjamin J Cowling; Kwok-Hung Chan; Vicky J Fang; Calvin K Y Cheng; Rita O P Fung; Winnie Wai; Joey Sin; Wing Hong Seto; Raymond Yung; Daniel W S Chu; Billy C F Chiu; Paco W Y Lee; Ming Chi Chiu; Hoi Che Lee; Timothy M Uyeki; Peter M Houck; J S Malik Peiris; Gabriel M Leung
Journal:  Ann Intern Med       Date:  2009-08-03       Impact factor: 25.391

6.  Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?

Authors:  K Johansen; D Brasseur; N MacDonald; H Nohynek; J Vandeputte; D Wood; P Neels
Journal:  Biologicals       Date:  2016-06-18       Impact factor: 1.856

7.  Five steps to conducting a systematic review.

Authors:  Khalid S Khan; Regina Kunz; Jos Kleijnen; Gerd Antes
Journal:  J R Soc Med       Date:  2003-03       Impact factor: 18.000

8.  Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study.

Authors:  Liam J Donaldson; Paul D Rutter; Benjamin M Ellis; Felix E C Greaves; Oliver T Mytton; Richard G Pebody; Iain E Yardley
Journal:  BMJ       Date:  2009-12-10

Review 9.  Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines.

Authors:  Saranya Sridhar; Karl A Brokstad; Rebecca J Cox
Journal:  Vaccines (Basel)       Date:  2015-04-24

10.  Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Sonja J Olsen; Joseph S Bresee; Karen R Broder; Ruth A Karron
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-08-07       Impact factor: 17.586

View more
  26 in total

1.  Factors associated with influenza vaccination of general medicine interns in Nancy, France, in 2017.

Authors:  Cossi Angelo Attinsounon; Clémence Cordonnier; Céline Pulcini; Paolo Di-Patrizio; Nathalie Thilly; Thierry May
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-13       Impact factor: 3.267

2.  Improving influenza vaccination uptake among healthcare workers by on-site influenza vaccination campaign in a tertiary children hospital.

Authors:  Melahat Melek Oguz
Journal:  Hum Vaccin Immunother       Date:  2019-03-19       Impact factor: 3.452

3.  100 years since the 1918 influenza pandemic.

Authors:  Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2018-03-04       Impact factor: 3.452

4.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

5.  Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies.

Authors:  Xinhui Wu; Haixia Yang; Sixian He; Ting Xia; Diang Chen; Yexin Zhou; Jin Liu; MengSi Liu; Zhen Sun
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 6.  Influenza vaccines: Evaluation of the safety profile.

Authors:  Claudia Maria Trombetta; Elena Gianchecchi; Emanuele Montomoli
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

7.  Trends in seasonal influenza vaccine coverage of target groups in France, 2006/07 to 2015/16: Impact of recommendations and 2009 influenza A(H1N1) pandemic.

Authors:  Pierre Verger; Lisa Fressard; Sébastien Cortaredona; Daniel Lévy-Bruhl; Pierre Loulergue; Florence Galtier; Aurélie Bocquier
Journal:  Euro Surveill       Date:  2018-11

8.  Seasonal Influenza Vaccination in Health Care Workers. A Pre-Post Intervention Study in an Italian Paediatric Hospital.

Authors:  Francesco Gilardi; Guido Castelli Gattinara; Maria Rosaria Vinci; Marta Ciofi Degli Atti; Veronica Santilli; Rita Brugaletta; Annapaola Santoro; Rosina Montanaro; Luisa Lavorato; Massimiliano Raponi; Salvatore Zaffina
Journal:  Int J Environ Res Public Health       Date:  2018-04-24       Impact factor: 3.390

9.  Impact of funding influenza vaccination on coverage among Australian children: a national study using MedicineInsight, a large general practice database.

Authors:  Carla De Oliveira Bernardo; David Alejandro González-Chica; Nigel Stocks
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

10.  In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Nicolas Fakhry; Tareck Ayad; Sven Saussez
Journal:  Laryngoscope       Date:  2020-06-30       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.